By expenditures
| Name | Title | Type |
|---|---|---|
| Lindsay Pearson | Chief Financial Officer | Auditee |
| James Lacroix | Partner | Auditee |
| Christy Yoakum | Managing Director | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 371623 | 2025 | 2025-10-31 | FORVIS MAZARS | $2.63M |
| 330026 | 2024 | 2024-11-26 | Forvis Mazars LLP | $3.49M |
| 9941 | 2023 | 2024-01-05 | Cohnreznick LLP | $3.57M |
| 54750 | 2022 | 2022-12-26 | Forvis LLP | $5.27M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 9941 | 2023 | 2024-01-05 | 584043 | 2023-001 | Significant Deficiency | - | N |
| 9941 | 2023 | 2024-01-05 | 584042 | 2023-001 | Significant Deficiency | - | N |
| 9941 | 2023 | 2024-01-05 | 584041 | 2023-001 | Significant Deficiency | - | N |
| 9941 | 2023 | 2024-01-05 | 584040 | 2023-001 | Significant Deficiency | - | N |
| 9941 | 2023 | 2024-01-05 | 7601 | 2023-001 | Significant Deficiency | - | N |
| 9941 | 2023 | 2024-01-05 | 7600 | 2023-001 | Significant Deficiency | - | N |
| 9941 | 2023 | 2024-01-05 | 7599 | 2023-001 | Significant Deficiency | - | N |
| 9941 | 2023 | 2024-01-05 | 7598 | 2023-001 | Significant Deficiency | - | N |
| 54750 | 2022 | 2022-12-26 | 634583 | 2022-001 | Significant Deficiency | - | ABL |
| 54750 | 2022 | 2022-12-26 | 58141 | 2022-001 | Significant Deficiency | - | ABL |